Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Mar 6, 2026, 4:00 PM EST
1.130
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:10 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.29 million as of March 6, 2026. Its market cap has decreased by -43.84% in one year.
Market Cap
25.29M
Enterprise Value
-42.74M
1-Year Change
-43.84%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.29M, a decrease of -92.89%. That is a compound annual growth rate of -74.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 25.07M | -6.67% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 27.02M |
| FibroBiologics | 26.31M |
| Evaxion | 26.02M |
| Passage Bio | 25.43M |
| Hyperion DeFi | 25.28M |
| Reviva Pharmaceuticals Holdings | 25.16M |
| Senti Biosciences | 25.00M |
| Lixte Biotechnology Holdings | 24.83M |